Toxicities of adenosine and 2'-deoxyadrenosine in L cells treated with inhibitors of adenosine deaminase.
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000241:Adenosine / Q000494:pharmacology*; D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001381:Azepines / Q000494:pharmacology; D003839:Deoxyadenosines / Q000494:pharmacology*; D003853:Deoxyribonucleosides / Q000494:pharmacology; D005347:Fibroblasts / Q000378:metabolism; D007739:L Cells / Q000187:drug effects* / Q000201:enzymology; D051379:Mice; D009700:Nucleoside Deaminases / Q000037:antagonists & inhibitors*; D014740:Vidarabine / Q000494:pharmacology
D058892:Adenosine Deaminase Inhibitors; D000900:Anti-Bacterial Agents; D001381:Azepines; D003839:Deoxyadenosines; D003853:Deoxyribonucleosides; D009700:Nucleoside Deaminases; D014740:Vidarabine; D000225:Adenine; D000241:Adenosine